Intellectus Partners’s Athenahealth, Inc. ATHN Stock Holding History

Intellectus Partners’s Portfolio ATHN Stock Details ATHN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-1,000	Closed	-$6K	–	823
2017 Q2	$6K	Buy	+1,000	New	+$125K	﹤0.01%	651

Other funds holding ATHN

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return

Intellectus Partners's ATHN Position: Q4 2018 in Review

Intellectus Partners sold out of Athenahealth, Inc. (ATHN) in Q4 2018, closing a stake of 1,000 shares — an estimated $134K sold.

Intellectus Partners first reported a position in ATHN in Q4 2016 and held it in 8 quarters. The position peaked at $159K in Q2 2018. 263 funds tracked by Wall St. Rank hold ATHN as of Q4 2018.

Intellectus Partners reported no remaining Athenahealth, Inc. position as of Q4 2018 after selling out during the quarter.
Intellectus Partners sold 1,000 Athenahealth, Inc. shares in Q4 2018, an estimated $134K.
Intellectus Partners first reported a position in Athenahealth, Inc. in Q4 2016 and held it in 8 quarters.
Intellectus Partners's Athenahealth, Inc. position peaked at $159K in Q2 2018.
263 funds tracked by Wall St. Rank held Athenahealth, Inc. as of Q4 2018.

Based on Intellectus Partners's 13F filing for Q4 2018, filed 14 Feb 2019.